US FDA

Responding to FDA Form 483 Observations

How to structure a response that addresses root cause, meets FDA's timing expectations, and holds up at the next inspection.

What this course covers

This course covers FDA's expectations for 483 response timing, what changes after the standard 15 business day window, and how to structure a response that addresses the actual root cause rather than restating the observation. It also covers how CAPA commitments made in a 483 response get tracked and verified at the next inspection, since a commitment made and not kept is worse than no commitment at all.

Who this course is for

QA management responsible for drafting or approving 483 responses
Site leadership involved in regulatory response strategy
Anyone who may be called on to support an inspection response effort

What you'll learn

FDA's expectations for 483 response timing and what happens beyond the 15 business day window
How to structure a response that addresses root cause, not just the symptom FDA observed
The most common mistakes that weaken a 483 response and increase warning letter risk
How CAPA commitments made in a response are tracked and verified at the next inspection
The relationship between response quality and how FDA classifies the inspection outcome

Why it matters

A weak 483 response is one of the most common paths from an observation to a warning letter. FDA is explicit that it evaluates the adequacy of the response itself, not just whether one was submitted on time. Getting this right the first time matters more than most sites treat it.

Included in the full GMPify subscription

Completion certificate, PDF slide download, and access to the complete GMP course library from day one.

Start this course →